{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-028300","form_type":"8-K","ticker":"BBLG","cik":"0001419554","company_name":"Bone Biologics Corp","filed_at":"2022-10-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.588545+00:00","generated_at":"2026-06-23T03:47:53.285495+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Bone Biologics closes $5.1M public offering of 3.78M units at $1.35/unit","bullets":["Gross proceeds of $5.1M from offering of 3,777,778 units at $1.35 per unit.","Each unit includes one common share and three Series A, B, C warrants exercisable at $1.62, $1.35, $2.16 respectively.","Warrants expire five years from issuance; Series C warrants eligible for cashless exercise upon $10M volume trigger.","Net proceeds to fund clinical trials, patent portfolio, CRO retention, and working capital.","WallachBeth Capital acted as sole book-runner; over-allotment option partially exercised for 556,037 warrants."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-028300","json":"https://secwatch.observer/filing/0001493152-22-028300.json","markdown":"https://secwatch.observer/filing/0001493152-22-028300.md","text":"https://secwatch.observer/filing/0001493152-22-028300.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419554/000149315222028300/0001493152-22-028300-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419554/000149315222028300/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T03:47:53.285495+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}